1. Home
  2. GLBS vs PLRX Comparison

GLBS vs PLRX Comparison

Compare GLBS & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Maritime Limited

GLBS

Globus Maritime Limited

N/A

Current Price

$2.96

Market Cap

56.1M

ML Signal

N/A

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

N/A

Current Price

$0.71

Market Cap

61.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GLBS
PLRX
Founded
2006
2015
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.1M
61.1M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
GLBS
PLRX
Price
$2.96
$0.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
119.5K
★ 303.1K
Earning Date
11-16-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 29.97
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$39.12
N/A
Revenue Next Year
$2.76
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$0.73
52 Week High
$4.06
$1.72

Technical Indicators

Market Signals
Indicator
GLBS
PLRX
Relative Strength Index (RSI) 48.27 22.06
Support Level $2.71 N/A
Resistance Level $3.19 $1.26
Average True Range (ATR) 0.18 0.04
MACD 0.04 -0.01
Stochastic Oscillator 72.41 9.30

Price Performance

Historical Comparison
GLBS
PLRX

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: